-
Global leader in advanced forestry genetics
-
Operating in the world’s major commercial tree species
-
In geographies with high annual planting rates
-
Sales to major forestry players in those countries
-
Leading market position in each market
-
Pre-eminent intellectual property position
-
Industry-leading genetic library
-
Proprietary ‘tree machine’ platform
-
Extensive database of global trials
-
Varietal and transgenic technology
-
Advanced genomics platform
-
Protection of patents and trade secrets
-
Portfolio of advanced products not requiring regulatory approval – now being commercialised
-
Heavy investment in research, capability, and customer preparation has been made
-
Now all about commercialising that investment – i.e. ‘converting’ customers to advanced genetics. ArborGen is well positioned to do so.